{
    "code": "02024959",
    "time": "2015-07-24 06:09:44",
    "許可證字號": "衛署藥輸字第024959號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/01\/16",
    "發證日期": "98\/01\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202495903",
    "中文品名": "保栓通膜衣錠 300 毫克",
    "英文品名": "PLAVIX film-coated tablets 300mg",
    "適應症": "降低近期發生中風、心肌梗塞或周邊動脈血管疾病的粥狀動脈硬化病人之粥狀動脈栓塞事件(如:心肌梗塞、中風或其他因血管病變引起的死亡)的發生。與aspirin併用降低非ST段上升之急性冠心症(不穩定性心絞痛和非Q波型心肌梗塞)病人（包括經皮冠狀動脈介入性治療後放置支架的患者）之粥狀動脈栓塞事件。與aspirin併用可用於以內科治療的ST段上升之急性心肌梗塞病人。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000顆鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "CLOPIDOGREL HYDROGEN SULPHATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市松山區復興北路337號12、13、14樓",
    "主製造廠": {
        "製造廠名稱": "F150008000  SANOFI WINTHROP INDUSTRIE",
        "製造廠廠址": "1,RUE DE LA VIERGE AMBARES ET LAGRAVE 33565 CARBON BLANC CEDEX, FRANCE",
        "製造廠公司地址": "",
        "製造廠國別": "FRANCE",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F150314000  Sanofi Clir",
            "製造廠廠址": "54 Avenue de la Boetie, 75008, Paris, France",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012600220",
            "成分名稱": "CLOPIDOGREL HYDROGEN SULPHATE",
            "含量描述": "",
            "含量": "391.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 Plavix 300mg_leaflet_E_CCDS v19_approved-104-05-13.pdf Plavix 300mg_leaflet_C_CCDS v19_approved-104-05-13.pdf Plavix 300mg_leaflet_E_CCDS v18_approved-2014-02-05.pdf Plavix 300mg_leaflet_C_CCDS v18_approved-2014-02-05.pdf Plavix 300mg_leaflet_E_CCDS v17_approved-102-09-05.pdf Plavix 300mg_leaflet_C_CCDS v17-102-09-05.pdf Plavix 300mg_leaflet_E_CCDS v16_approved-102-06-13.pdf Plavix 300mg_leaflet_C_CCDS v16_approved-102-06-13.pdf Plavix 300mg_leaflet_C_CCDS v16_approved-102-06-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024959&Seq=009&Type=9"
        }
    ]
}